JPMORGAN CHASE & CO - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$5,079,174
-12.5%
1,670,781
-5.3%
0.00%0.0%
Q2 2023$5,804,616
+46.6%
1,764,321
+41.7%
0.00%
Q1 2023$3,959,000
+44139.6%
1,244,967
-3.7%
0.00%
-100.0%
Q4 2022$8,949
-99.9%
1,293,046
+5.4%
0.00%0.0%
Q3 2022$7,766,000
+10.0%
1,226,870
-28.1%
0.00%0.0%
Q2 2022$7,060,000
-21.9%
1,705,489
-8.5%
0.00%0.0%
Q1 2022$9,042,000
-59.2%
1,864,533
-15.9%
0.00%
-66.7%
Q4 2021$22,136,000
-40.1%
2,215,910
+14.7%
0.00%
-40.0%
Q3 2021$36,935,000
-29.1%
1,932,697
+18.6%
0.01%
-16.7%
Q2 2021$52,110,000
+57.9%
1,629,452
+48.8%
0.01%
+50.0%
Q1 2021$33,010,000
+19.7%
1,094,892
+71.8%
0.00%0.0%
Q4 2020$27,576,000
+139.7%
637,289
+204.6%
0.00%
+100.0%
Q3 2020$11,506,000
-0.5%
209,191
+10.4%
0.00%0.0%
Q2 2020$11,563,000
+77.5%
189,433
+33.6%
0.00%0.0%
Q1 2020$6,516,000
-25.0%
141,782
+43.2%
0.00%0.0%
Q4 2019$8,685,000
+41.5%
98,991
+48.1%
0.00%
+100.0%
Q3 2019$6,139,000
-14.8%
66,863
+15.0%
0.00%0.0%
Q2 2019$7,205,000
-24.7%
58,140
-4.4%
0.00%
-50.0%
Q1 2019$9,566,000
+92.3%
60,803
+21.3%
0.00%
+100.0%
Q4 2018$4,975,000
-33.8%
50,144
-2.6%
0.00%0.0%
Q3 2018$7,513,000
-58.5%
51,460
-55.4%
0.00%
-75.0%
Q2 2018$18,108,000
-19.9%
115,376
-12.9%
0.00%
-20.0%
Q1 2018$22,616,000
+88.0%
132,456
+96.1%
0.01%
+66.7%
Q4 2017$12,028,000
+58.9%
67,536
+25.9%
0.00%
+50.0%
Q3 2017$7,571,000
+30.4%
53,636
-2.9%
0.00%
+100.0%
Q2 2017$5,805,000
-9.0%
55,255
-21.3%
0.00%0.0%
Q1 2017$6,379,000
-34.7%
70,170
-55.7%
0.00%
-50.0%
Q4 2016$9,765,000
+47.6%
158,258
+62.2%
0.00%0.0%
Q3 2016$6,614,000
+79.2%
97,589
+14.5%
0.00%
+100.0%
Q2 2016$3,690,000
+45.6%
85,235
+43.0%
0.00%0.0%
Q1 2016$2,535,000
-29.2%
59,623
+7.0%
0.00%0.0%
Q4 2015$3,579,000
-35.6%
55,717
-14.3%
0.00%0.0%
Q3 2015$5,559,000
-73.2%
64,999
-47.3%
0.00%
-80.0%
Q2 2015$20,767,000
+21.2%
123,346
-13.1%
0.01%
+25.0%
Q1 2015$17,137,000
+37.3%
141,905
+4.3%
0.00%
+33.3%
Q4 2014$12,480,000
+479.7%
136,072
+126.9%
0.00%
+200.0%
Q3 2014$2,153,000
+531.4%
59,976
+374.9%
0.00%
Q3 2013$341,00012,6300.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders